Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2026 07:00 ET | Source: Asimov

Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies

Mabylon AG leveraged Asimov's lead optimization offering, Rapid Pools, to de-risk candidate selection before advancing into cell line development.
March 19, 2026 07:00 ET | Source: Asimov

Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates

RNA Edge combines AI sequence optimization, novel genetic parts, and validation in application-relevant cell models to improve expression and half-life.
March 17, 2026 07:00 ET | Source: Asimov

Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics

Asimov partners with Score Pharma to develop biosuperior antibody therapeutics with enhanced ADCC activity using Asimov's CHO Edge platform.